Get started
Author

Christian Becker

NT-proBNP as a Marker for Atrial Fibrillation and Heart Failure in Four Observational Outpatient Trials
2021 · Stefanie M. Werhahn, Christian Becker, et al. · ESC Heart Failure · 58
Patient characteristics and valuation changes impact quality of life and satisfaction in total knee arthroplasty – results from a German prospective cohort study
2019 · Julia Felix, Christian Becker, et al. · Health and Quality of Life Outcomes · 27
PDF
Simulation study on LDL cholesterol target attainment, treatment costs, and ASCVD events with bempedoic acid in patients at high and very-high cardiovascular risk
2022 · Julius L. Katzmann, Christian Becker, et al. · PLoS ONE · 21
PDF
Manual Compression versus Vascular Closing Device for Closing Access Puncture Site in Femoral Left-Heart Catheterization and Percutaneous Coronary Interventions: A Retrospective Cross-Sectional Comparison of Costs and Effects in Inpatient Care
2016 · Julia Walter, Matthias Vogl, et al. · Value in Health · 21
A pilot study on patient-related costs and factors associated with the cost of specialist palliative care in the hospital: first steps towards a patient classification system in Germany
2018 · Christian Becker, Reiner Leidl, et al. · Cost Effectiveness and Resource Allocation · 19
PDF
Should health insurers target prevention of cardiovascular disease?: a cost-effectiveness analysis of an individualised programme in Germany based on routine data
2014 · Majed Aljutaili, Christian Becker, et al. · BMC Health Services Research · 19
PDF
Patients with coronary artery disease after acute myocardial infarction: effects of continuous enrollment in a structured Disease Management Program on adherence to guideline-recommended medication, health care expenditures, and survival
2020 · Florian Kirsch, Christian Becker, et al. · The European Journal of Health Economics · 16
PDF
Cost-of-illness studies of atrial fibrillation: methodological considerations
2014 · Christian Becker · Expert Review of Pharmacoeconomics & Outcomes Research · 13
The quality of three decision-analytic diabetes models: a systematic health economic assessment
2011 · Christian Becker, Astrid Langer, et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 13
Estimating Prevalence and Characteristics of Statin Intolerance among High and Very High Cardiovascular Risk Patients in Germany (2017 to 2020)
2023 · Klaus Parhofer, Anastassia Anastassopoulou, et al. · Journal of Clinical Medicine · 9
PDF
Effects of adherence to pharmacological secondary prevention after acute myocardial infarction on health care costs – an analysis of real-world data
2020 · Florian Kirsch, Christian Becker, et al. · BMC Health Services Research · 9
PDF
The excess health care costs of KardioPro, an integrated care program for coronary heart disease prevention
2015 · Christian Becker, Rolf Holle, et al. · Health Policy · 9
Oral triple combination lipid-lowering therapy and LDL cholesterol goal attainment: a simulation using the SANTORINI study cohort
2025 · Julius L Katzmann, Kausik K Ray, et al. · European Journal of Preventive Cardiology · 6
Expert opinions on good practice in evaluation of health promotion and primary prevention measures related to children and adolescents in Germany
2017 · Katharina Korber, Christian Becker · BMC Public Health · 6
PDF
LDL-cholesterol goal attainment with ezetimibe and bempedoic acid in patients at high and very-high cardiovascular risk: A simulation study in the Italian cohort of the SANTORINI study
2024 · Marcello Arca, Angela Pirillo, et al. · European Atherosclerosis Journal · 4
PDF
The Effectiveness of the Cardiovascular Disease Prevention Programme ‘KardioPro’ Initiated by a German Sickness Fund: A Time-to-Event Analysis of Routine Data
2014 · Sabine Witt, Reiner Leidl, et al. · PLoS ONE · 3
PDF
Real-World Effectiveness of Bempedoic Acid in Reducing LDL-C
2026 · Julius L. Katzmann, Christian Becker, et al. · JACC Advances · 2
Potential impact on cholesterol goal achievement and predicted cardiovascular risk by the addition of ezetimibe and bempedoic acid on top of statins: a simulation from the SANTORINI study
2026 · Kausik K. Ray, Carlos Aguiar, et al. · American Journal of Preventive Cardiology · 1
Lipid management in high cardiovascular risk patients in France: a comparison with rest of Europe patients from 1-year follow-up of SANTORINI
2026 · Jean Ferrières, Kausik K. Ray, et al. · Frontiers in Cardiovascular Medicine · 1
PDF
P2640NT-proBNP is a more sensitive and specific biomarker for the prediction of future atrial fibrillation than for forthcoming onset of heart failure: results from the observational DIAST-CHF study
2017 · S. Werhahn, C. Becker, et al. · European Heart Journal · 1
Predicted change in 10-year cardiovascular risk one year after initiation of bempedoic acid-based therapy in the MILOS study
2026 · K G Parhofer, M Averna, et al. · European Heart Journal
PDF
From prescription to outcome: real-world utilization of direct oral anticoagulants in atrial fibrillation across Europe
2026 · R S Bodes, R Wang, et al. · EP Europace
Triple oral lipid-lowering treatment pathway and associated outcomes in high- and very high-cv risk patients: a simulation using the SANTORINI study cohort
2025 · J L Katzmann, K K Ray, et al. · European Heart Journal
Real-world effectiveness of bempedoic acid therapy on the reduction of low-density lipoprotein cholesterol levels in Germany
2025 · J L Katzmann, C Becker, et al. · European Heart Journal
Simulation of ezetimibe and Bempedoic acid effect on LDL-C goal attainment in statin-intolerant patients across Europe: The 1-year follow-up Santorini observational study
2024 · Michel Farnier, Kausik Ray, et al. · Atherosclerosis
Works count: 32
Citation count: 258
H-index: 9
I10-index: 9
Year
Topic
Type